UK silent heart attack market is estimated to grow considerably at a CAGR of around 6.8% during the forecast period. UK has one of the finest healthcare systems in the EU region which enables it to provide quality healthcare to the individual citizens. According to British Heart Foundation, more than 7 million people are living with one or the other type of heart diseases in UK. Lingering heart diseases put economic burden to the UK government which includes cost of premature deaths, lost productivity, hospital stay and prescriptions which are estimated to be around $50 billion annually. According to the British Heart Foundation, 0.17 million heart attacks occur every year in UK. In which 0.11 million men and 0.06 million women lose their life annually in UK due to heart attack each year.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/uk-silent-heart-attack-market

UK silent heart attack market is segmented into diagnosis, treatment, and end-user. Based on the diagnosis, the market is segmented into an electrocardiography (ECG), chest x-ray, computed tomography (CT Scan), echocardiography, and others (blood test). Based on treatment, the market is segmented into medication and surgery. Based on end-user, the market is segmented into hospitals & clinics and ambulatory surgical centers (ASCs). Significant availability of hospitals coupled with the presence of skilled professionals with different specialties in hospitals is contributing to the treatment if silent heart attack in hospitals and clinics. Therefore, hospitals and clinics are mainly preferred for the treatment of CVD conditions.

A Full Report of UK Silent heart attack Market is Available at: https://www.omrglobal.com/industry-reports/uk-silent-heart-attack-market

The companies which are contributing to the growth of the UK silent heart attack market include AstraZeneca PLC, Bayer AG, Siemens AG, F. Hoffmann-La Roche Ltd., Boehringer Ingelheim GmbH, and GlaxoSmithKline Plc. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market.



UK Silent heart attack Market Segmentation
UK Silent Heart Attack Market by Diagnosis
• Electrocardiography (ECG)
• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT Scan)
• Echocardiography
• Others (Blood Test)


UK Silent Heart Attack Market by Treatment
• Medication
• Surgery
o Angioplasty
o Bypass Surgery
o Heart Transplant

UK Silent Heart Attack Market by End-Users
• Hospital & Clinics
• Ambulatory Surgical Centers

UK Silent heart attack Market – Segment by Region
North America
• United States
• Canada

Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World
• Latin America
• Middle East and Africa

Company Profiles
• Astellas Pharma Inc.
• AstraZeneca PLC
• Bayer AG
• Boehringer Ingelheim GmbH
• Boston Scientific Corp.
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Medtronic PLC
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Siemens AG
• Takeda Pharmaceutical Co. Ltd.


For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/uk-silent-heart-attack-market

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404